Werner Kroll
Chief Tech/Sci/R&D Officer at QUIDELORTHO CORPORATION
Net worth: 2 M $ as of 2024-03-30
Profile
Werner Kroll is Senior Vice President-Research & Development at Quidel Corp. Dr. Kroll is also on the board of European Personalised Medicine Association. Dr. Kroll previously was VP & Head-Research & Innovation at Novartis Institutes for Biomedical Research, Inc. Dr. Kroll received a doctorate from Philipps University of Marburg.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
QUIDELORTHO CORPORATION
0.05% | 2024-03-27 | 35,781 ( 0.05% ) | 2 M $ | 2024-03-30 |
Werner Kroll active positions
| Companies | Position | Start |
|---|---|---|
| QUIDELORTHO CORPORATION | Chief Tech/Sci/R&D Officer | - |
| European Personalised Medicine Association | Director/Board Member | - |
Former positions of Werner Kroll
| Companies | Position | End |
|---|---|---|
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 2021-12-31 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Werner Kroll
| Philipps University of Marburg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| European Personalised Medicine Association | |
| QuidelOrtho Corp. |
- Stock Market
- Insiders
- Werner Kroll
